Newbridge Financial Services Group’s MEI Pharma MEIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.94K | Hold |
1,999
| – | – | ﹤0.01% | 1027 |
|
|
2025
Q1 | $4.38K | Hold |
1,999
| – | – | ﹤0.01% | 814 |
|
|
2024
Q4 | $4.92K | Hold |
1,999
| – | – | ﹤0.01% | 868 |
|
|
2024
Q3 | $5.7K | Hold |
1,999
| – | – | ﹤0.01% | 497 |
|
|
2024
Q2 | $5.82K | Hold |
1,999
| – | – | ﹤0.01% | 812 |
|
|
2024
Q1 | $8K | Hold |
1,999
| – | – | ﹤0.01% | 816 |
|
|
2023
Q4 | $11.6K | Hold |
1,999
| – | – | 0.01% | 705 |
|
|
2023
Q3 | $14K | Hold |
1,999
| – | – | 0.01% | 734 |
|
|
2023
Q2 | $13.2K | Buy |
1,999
+1,449
| +263% | +$9.53K | 0.01% | 821 |
|
|
2023
Q1 | $2.52K | Hold |
550
| – | – | ﹤0.01% | 1167 |
|
|
2022
Q4 | $2.68K | Hold |
550
| – | – | ﹤0.01% | 1172 |
|
|
2022
Q3 | $4K | Hold |
550
| – | – | ﹤0.01% | 1084 |
|
|
2022
Q2 | $7K | Buy |
550
+250
| +83% | +$3.18K | ﹤0.01% | 945 |
|
|
2022
Q1 | $4K | Hold |
300
| – | – | ﹤0.01% | 1148 |
|
|
2021
Q4 | $16K | Buy |
300
+50
| +20% | +$2.67K | 0.01% | 793 |
|
|
2021
Q3 | $14K | Hold |
250
| – | – | 0.01% | 775 |
|
|
2021
Q2 | $14K | Buy |
250
+50
| +25% | +$2.8K | 0.01% | 886 |
|
|
2021
Q1 | $14K | Hold |
200
| – | – | 0.01% | 794 |
|
|
2020
Q4 | $11K | Hold |
200
| – | – | 0.01% | 696 |
|
|
2020
Q3 | $12K | Buy |
+200
| New | +$12K | 0.01% | 629 |
|